Great News for Eli Lilly Stock Investors!

By Parkev Tatevosian, CFA – Apr 7, 2026 at 4:17PM ESTEli Lilly (LLY +2.38%) gained major approval for a new weight-loss treatment poised to generate billions in revenue. *Stock prices used were the afternoon prices of April 3, 2026. The video was published on April 5, 2026. Read NextApr 8, 2026 •By Adria CiminoWhich of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?Apr 7, 2026 •By Prosper Junior BakinyIs Eli Lilly Stock a Buy After a Brand New Approval?Apr 6, 2026 •By Lyle DalyThe Largest Healthcare Companies by Market Cap in April 2026Apr 4, 2026 •By Justin PopeEli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug FightApr 2, 2026 •By Adria CiminoPrediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.)Apr 1, 2026 •By Lyle DalyThe Largest Companies by Market Cap in April 2026About the AuthorA Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.TMFParkevX@TMFParkevStocks MentionedEli LillyNYSE: LLY$953.30(+2.38%)+$22.21*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.